Lepu Medical Technology (Beijing) Co., Ltd.,the leading manufacturer and innovational company from China, is all set to make its foray into Indian medical devices and equipment market through an overseas subsidiary company, Lepucare (India) Vascular Solutions Pvt. Ltd., only the Fifth overseas subsidiary of its, globally.

Aaron Lin, vice president, Lepu Medical, Harrison Wang, managing director, Lepu India, Victor, GM, Lepu India and  Jitendra R Kulkarni, director sales, Lepu India, announced Lepu Medical’s India entry and their plans for the country in Hyderabad.

Established in 1999, Lepu Medical specialises in developing, manufacturing and distribution of high-tech medical devices, equipment, mobile medical service and pharmaceutical. It is dedicated to reach its state-of-the-art technologies and services to patients and doctors, through its global foot print.

Lepu is beginning its India operation from this month and has hired senior and experienced professionals to establish and make a mark in the market. Lepu will set up a fully functional operation organization with 95% Indian employees. It will be launching the whole range of PCI products and bring its the structure heart products and others' in the near future in a staggered manner. The products being launched will be made available across the length and breadth of the country.

As per the Wuhan summit spirit, held on April 26-27, between Indian Prime Minister Narendra Modi and Chinese President Xi Jinping, the aim of Beijing proposed Belt and Road Initiative is to improve infrastructure connectivity along the two land and sea routes of the ancient Silk Road. Along the Belt and Road program, LEPU together with the national centre for cardio vascular diseases and the No.1 Cardiovascular hospital, Fuwai hospital, will offer the PCI and occlude procedure training program for the talented doctors in The Belt and Road countries. We would like to invite the talented doctors from India to join us in this forthcoming program for the benefit of the Indian patients in the long term, adds Aaron Lin

Our USP is, products are world class and reliable, while being within the affordable reach of the Indian patient. Our India office will be located in New Delhi and will set up branch offices in other cities depending on the operational requirement, says Mr Jitendra R Kulkarni.

India has grown into one of the prime markets for medical devices and equipment, the demand here will far outstrip that of the current leading markets in America and Europe. Our entry into India, we consider is at an opportune time and will ensure arrival of the most innovative technology while making the market highly competitive through our affordable products, says Aaron Lin.

Lepu Medical, which is a global player in the medical devices and equipment market, has four other overseas subsidiaries companies in United States, Netherlands, France and Turkey.

In a Subsidiary, LEPU group is either a majority shareholder or it is a joint venture company with the local partner. In India the arrangement Lepu has is to set up a fully functional operation organization and will have 95% employees from India. It obtained local registrations in 27 countries and built the sales and distribution channels in over 80 countries and regions. Currently 119 of its products received CE certificates and 11 products have FDA approvals.

It has presence with products in all major medical specialties including cardiovascular, neurovascular and peripheral vascular interventions, structural heart diseases, surgical cardiology, cardiac rhythm management, anesthesia and critical care, in vitro diagnostics and general surgery.